NCT04185441

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

National, Multicenter, Randomized, Double-blind, Double-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 295 (actual)
• Sponsor: EMS · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Tanzânia association in adults with erectile dysfunction associated with Benign Prostatic Hyperplasia.

Conditions

• Erectile Dysfunction
• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	Tanzânia association	Tanzânia association capsule
DRUG	Omnic Ocas	Tamsulosin 0,4 mg
OTHER	Omnic Ocas placebo	Tamsulosin placebo
OTHER	Tanzânia association placebo	EMS association placebo

Timeline

• Start date: 2021-03-14
• Primary completion: 2023-10-10
• Completion: 2024-07-05
• First posted: 2019-12-04
• Last updated: 2025-12-08

Locations

1 site across 1 country: Brazil